CATAPRES-TTS-3

LOE Approaching

clonidine transdermal system

Lavipharm
NDATRANSDERMALSYSTEM
Approved
Oct 1984
Lifecycle
LOE Approaching
Competitive Pressure
30/100

Mechanism of Action

Adrenergic alpha2-Agonists

Pharmacologic Class:

Central alpha-2 Adrenergic Agonist

Indications (2)

the treatment of hypertensionhypertension
Company
Lavipharm
Lavipharm
France - Paris
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers